Nelson, Van Denburg & Campbell Wealth Management »

Perspective Therapeutics shares owned by Nelson, Van Denburg & Campbell Wealth Management

Quarter-by-quarter ownership of Perspective Therapeutics shares owned by Nelson, Van Denburg & Campbell Wealth Management from 13F filings

Historical chart of Nelson, Van Denburg & Campbell Wealth Management investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Nelson, Van Denburg & Campbell Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Nelson, Van Denburg & Campbell Wealth Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $508 51 9.96

More positions owned by Nelson, Van Denburg & Campbell Wealth Management

Vanguard Growth Etf Etf (VUG)
Ishares Core Dividend Growth Etf Etf (DGRO)
Vanguard Index Fds Mid-cap Value Index Viper Shs Etf Etf (VOE)
Vanguard Mid Cap Growth Etf Etf (VOT)
Ishares S&p 500 Index Etf (IVV)
Jpmorgan Active Value Etf Etf (JAVA)
Jpmorgan Active Growth Etf Etf (JGRO)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Apple Stock (AAPL)
Ishares Morningstar Mid-cap Growth Etf Etf (IMCG)
Vanguard S&p 500 Etf Etf (VOO)
Invesco Bulletshares 2025 Corporate Bond Etf Etf (BSCP)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Invesco Bulletshares 2029 Corporate Bond Etf Etf (BSCT)
Invesco Bulletshares 2027 Corporate Bond Etf Etf (BSCR)

View all positions for Nelson, Van Denburg & Campbell Wealth Management

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management
Citadel Advisors
Affinity Asset Advisors

View all funds holding Perspective Therapeutics